Lipid Management

1. Front Matter

   Pages i-xiv

   PDF

2. Basics in Lipoprotein Metabolism

   • Hussein Yassine, Keenia Tappin, Muhammad Jawad Sethi

   Pages 1-16

3. Genetics of Lipid Disorders

   • Marija Sto ja nova Jordanov

   Pages 17-35

4. Lipid and Inflammation in Atherosclerosis

   • Imad Ahmado, Oliver G. Abela, Muhamad Adeeb Saffia, Abed Janoudi, George S. Abela

   Pages 37-63

5. Dyslipidemia: Relationship to Insulin Resistance, Fatty Liver, and Sub-Clinical Atherosclerosis

   • Claudia M. Toledo-Corral, Tanya L. Alderete, Michael I. Goran

   Pages 65-79

6. Is Low HDL Cholesterol a Marker or a Mediator of Cardiovascular Disease?

   • Hussein Yassine

   Pages 81-89

7. Approach to the Patient with Lipid Disorders

   • Kelsey Michiko Shikuma Lee, Hussein Yassine

   Pages 91-111

8. The Effects of Diet in Hyperlipidemia

   • Joseph Michael Allevato, Imelda Allevato

   Pages 113-121

9. Statins

   • Marija Stojanova Jordanov, Hiba Abou Assi

   Pages 123-147

10. Non-Alcoholic Fatty Liver Disease (NAFLD): The Lipid Disease of the Liver and the Effect of Statins

    • Mazen Noureddin, David Alexanian, Neil Kaplowitz

    Pages 149-173

11. The Role of Statins in Heart Failure

    • Allen Kuo, Michael Fong

    Pages 175-185

12. Statins in Chronic Kidney Disease

    • Sahar H. Koubar

    Pages 187-199

13. Non-Statin Treatment of Dyslipidemia

    • Stanley J. Goldberg

    Pages 201-231

14. LDL Apheresis

    • Hedyeh Shafi, Holli M. Mason, Ellen Klapper

    Pages 233-239

15. Dyslipidemia in HIV

    • Michael P. Dubé

    Pages 241-255

16. New and Emerging Therapies for Hyperlipidemia

    • Michael J. Wong

    Pages 257-266

17. Back Matter

    Pages 267-269

    PDF

This timely, concise title provides an important update on clinical lipid management. Using information from recent clinical trials and in special populations, the book begins by offering an easy-to-read overview of LDL, HDL, and triglyceride metabolism and the genetics of lipid disorders. The link between inflammation and lipids, and how this relates to atherosclerosis development, is also addressed, as are the measures of subclinical atherosclerosis in patients with abnormal lipid levels. Lipid abnormalities in children, with a particular focus on vulnerable populations (with an emphasis on ethnicity and childhood obesity), are covered. The treatment goals and approaches for managing lipids in the clinic are thoroughly discussed, emphasizing the important role of statin use and addressing controversies of lipid management in special populations such as heart failure, end stage kidney disease and fatty liver disease. Of special note, an important update on how new HIV medicationsimpact lipid levels is provided. In all, Lipid Management: From Basics to Clinic, is an invaluable, handy resource for understanding changes in lipids in different populations and for sharpening the clinical approach to managing complicated lipid cases.

• Body Mass Index
• Cardiovascular Risk
• Dyslipidemia
• Hypercholesterolemia
• Hyperlipidemia
• Lipidology
• Lipids
• Triglycerides

• University of Southern California Lipid Clinic, Los Angeles, USA

  Hussein Yassine

Hussein Yassine, MD is an Assistant Professor of Medicine-Endocrinology at the University of Southern California, where he directs the lipid clinic. His research focuses on cholesterol transport in cardiovascular disease. He was the winner of several research and teaching awards including the Department of Veterans Affairs VISN 18 Outstanding Research Award, and the Endocrine Society Presidential Award.

Policies and ethics